Actuate Therapeutics, Inc.

US$0.33As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ACTUHealthcare
Country USA
PE (Fwd) •••
TSR 2Y CAGR (76.82%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.53
PE TTM —
TSR TTM (95.06%)
Mkt cap US$18.08M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.404
22.74%
(73.38%)
Hold 3|4|11|0|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
0.01
0.01
0.01
17.48%
17.12%
18.28%
20.73%
Revenue$M
0.905
0.907
0.892
0.939
6.82%
6.84%
2.36%
6.98%
Peers (US$18.08M)
Cap (US$)
PE
17.91M
—
Capital
TTM
5Y
10Y
Leveragex
7.779
(0.553)
(0.476)
EBIT/Intx
1.258
0.075
0.099
Own earn%
(57.78)
(100.52)
(98.73)
Sh yield%
16.19
57.75
58.03
Owners
Insiders/Inst%
7.78
35.29
Short interest%
4.05
SBC / revenue%
4.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
18–28
$1 testx
0.0
Incr. ROIC%
12